ImmuneWorks' Unattributed Round

ImmuneWorks raised a round of funding on December 26, 2013.

ImmuneWorks is a clinical stage biotechnology company developing a therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases.…

Articles about ImmuneWorks' Unattributed Round: